Stryker Q1 net sales $6.0B up 2.6%; adjusted EPS down 8.5% to $2.60; maintains FY guidance

STRYKER CORP

2026-Q1 EPS reported $1.93 revenue$6,020,000,000

Net sales $6.0B (+2.6% reported, +2.4% organic); MedSurg/Neuro +5.0%, Orthopaedics +0.1%.
Reported EPS $1.93 (+14.2%); adjusted EPS $2.60 (-8.5%) as adjusted operating margin contracted 180bps to 21.1%.
Maintains FY2026 guidance: organic sales growth 8.0%-9.5%, adjusted EPS $14.90-$15.10.
Company highlights recovery from cyber incident and new Ortho Tech organizational structure combining Mako and instruments.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

STRYKER CORP updated its first quarter 2026 guidance (reaffirmed).

Period: first quarter 2026
Guidance: reaffirmed
Result: reported results

Exact text from the filing

Stryker Corporation issued a press release on April 30, 2026 announcing its first quarter 2026 operating results.

View on SEC.gov

51 earnings releases filed in the last 30 days. Browse all earnings releases →

STRYKER CORP filing history →

Source: SEC EDGAR

accession 0000310764-26-000025

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.